Australia markets closed

Benitec Biopharma Inc. (BNTC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.72-0.14 (-2.04%)
At close: 04:00PM EDT
6.54 -0.18 (-2.68%)
After hours: 07:34PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 17.42M
Enterprise value -2.53M
Trailing P/E 51.55
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)77.10
Price/book (mrq)1.13
Enterprise value/revenue -41.47
Enterprise value/EBITDA 0.12

Trading information

Stock price history

Beta (5Y monthly) 1.02
52-week change 397.65%
S&P500 52-week change 322.64%
52-week high 39.01
52-week low 31.86
50-day moving average 35.01
200-day moving average 33.61

Share statistics

Avg vol (3-month) 382.57k
Avg vol (10-day) 3413.5k
Shares outstanding 52.59M
Implied shares outstanding 68.34M
Float 82.02M
% held by insiders 12.12%
% held by institutions 117.14%
Shares short (28 Mar 2024) 410.96k
Short ratio (28 Mar 2024) 40.55
Short % of float (28 Mar 2024) 40.57%
Short % of shares outstanding (28 Mar 2024) 40.42%
Shares short (prior month 29 Feb 2024) 416.11k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 318 Nov 2019
Ex-dividend date 4N/A
Last split factor 21:17
Last split date 326 July 2023

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-35,560.66%

Management effectiveness

Return on assets (ttm)-81.53%
Return on equity (ttm)-178.30%

Income statement

Revenue (ttm)61k
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -21.6M
Net income avi to common (ttm)-21.81M
Diluted EPS (ttm)-236.13
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)20.37M
Total cash per share (mrq)7.86
Total debt (mrq)423k
Total debt/equity (mrq)2.73%
Current ratio (mrq)3.62
Book value per share (mrq)5.97

Cash flow statement

Operating cash flow (ttm)-18.07M
Levered free cash flow (ttm)-9.6M